2. Karnofsky D.A., Burchenal J.H. The clinical evalution of chemotherapeutic agents in Cancer. Evaluation of chemotherapeutic agenta. Columbia University Press. 1947:67–82.

3. Elkinton J.R. Medicine and the quality of life. Ann Intern Med. 1966;64:711–714.

4. Spitzer W.O. State of science 1986: quality of life and functional status as target variables for research. J Chronic Dis. 1987;40:465–471.

5. Bergner M. Measurement of health status. Med Care.1985;23:696–704.

6. Wenger N.K., Mattson M.E., Furberg C.D., Elinson J. Assessment of quality of life in clinical trials of cardiovascular therapies. Am J Cardiol. 1984;54:908–913.

7. Ware J.E. The status of health assessment 1994. Annu Rev Public Health. 1995;16:327–354.

8. Fanshel S., Bush J.W. A health-status index and its application to health-services outcomes. Oper Res. 1970;18:1021–1066.

9. Novik A.A., Ionova T.I. Guide to the study of quality of life in medicine. Moskva.: Olma Media Grupp. 2007;320 s. Russian (Новик А.А., Ионова Т.И.Руководство по исследованию качества жизни в медицине. Москва.: Олма Медиа Групп. 2007;320 с.).

10. World Health Organization. The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med. 2005;41(10):1403–1409.

11. Kaplan R.M., Bush J.W. Health-related quality of life measurement for evaluation research and policy analysis. Health Psychol. 1982;1:61–80.

12. Torrance G.W. Utility approach to measuring health-related quality of life. J Chronic Dis. 1987;40(6):593–600.

13. FDA, Guidance for Industry. Patient Reported Outcomes Measures: Use in Medical Product Development to Support Labeling Claims, 2009.

14. Leonova M.V. Patient outcomes in clinical trials. Kachestvennaya klinicheskaya praktika. 2016;2:38–45. Russian (Леонова М.В. Оценка исходов пациентами в клинических испытаниях. Качественная клиническая практика. 2016;2:38–45).

15. Zholdasbekova A.S., Kalmataeva Zh.A. Modern approaches to the study of the quality of life in medicine and cardiology. Vestnik. 2016;2:246–251. Russian (Жолдасбекова А.С., Калматаева Ж.А. Современные подходы к изучению качества жизни в медицине и кардиологии. Вестник. 2016;2:246–251).

16. OMS. The World Health Organization Quality of Life assessment (WHOQV): position paper from the World Health Organization. Soc. Sci. Med. 2005;41:1403.

17. Burkovskii G.V., Kotsyubinskii A.P., Levchenko E.V., Lomachenkov A.S. Creation of the Russian version of the World Health Organization tool for measuring the quality of life. Problems of optimization of a way of life and health of the person. SPb., 1995:27–28. Russian (Бурковский Г.В.,Коцюбинский А.П., Левченко Е.В., Ломаченков А.С. Создание русской версии инструмента Всемирной организации здравоохранения для измерения качества жизни. Проблемы оптимизации образа жизни и здоровья человека. СПб., 1995:27–28).

18. Skevington S.M., Lotfy M., O’Connell K.A. The World Health Organization’s WHOQOL-BREF quality of life assessment: Psychometric properties and results of the international field trial A Report from the WHOQOL Group. Quality of Life Res. 2004;13:299–310.

19. WHOQOL GROUP. The World Organization quality of life assessment (WHOQOL): Development and psychometric properties. Social Science Medicine, 1998;46:1585.

20. Bergner M., Bobitt R.A., Carter W.B. The Sickness Impact Profile: development and final revision of a health status measure. Med Care. 1981:14:787–805.

21. Ware J.E., Snow K.K., Kosinski M. SF-36 Health Survey Manual and Interpretation Guide. The Health Institute. Boston. 1993.

22. Ciconelli R.M., Ferraz M.B., Santos W. Brazilian-portuguese version of the SF-36. A reliable and valid quality of life outcome measure. Rev. Bras. Reumatol. 1999;39:143.

23. Cella D.F., Tulksy D.S., Gray G. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J. Clin. Oncol. 1993;11:570.

24. Sprangers M.A., Cull A., Groenvold M. The European Organization for Research and Treatment of Cancer approach to developing questionnaire modules: an update and overview. EORTC Quality of Life Study Group. Qual. Life Res. 1998;7: 291.

25. Barry M.J. Fowler F.J., O’Leary M.P. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J. Urol. 1992;148:1549–557; discussion 1564.

26. Rasner P.I., Gazimiev M.A., Gadzhieva Z.K., Kasyan G.R. Micturition disorders in men. M., ABV-press. 2017. 14 p. Russian (Раснер П.И., Газимиев М.А., Гаджиева З.К., Касян Г.Р. Расстройства мочеиспускания у мужчин. М., АБВ-пресс. 2017. 14 c).

27. Akilov F.A., Rakhmonov O.M., Mirkhamidov D.Kh. Assessment of the reliability and validity of the Uzbek and Russian versions of the questionnaire of the International Scale of Evaluation of Prostatic Symptoms – (IPSS). Eksperimental’naya i klinicheskaya urologiya. 2012;4:63–66. Russian (Акилов Ф.А., Рахмонов О.М., Мирхамидов Д.Х. Оценка надежности и валидности узбекской и русской версий опросника Международной Шкалы Оценки Простатических Симптомов – (IPSS). Экспериментальная и клиническая урология. 2012;4:63–66).

28. Schaeffer A.J., Datta N.S., Fowler J.E. Jr., Krieger J.N., Litwin M.S., Nadler R.B.,Nickel J.C., Pontari M.A., Shoskes D.A., Zeitlin S.I., Hart C. Chronic Prostatitis Collaborative Research Network. Overview summary statement. Diagnosis and management of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). Urology. 2002;60(6):1–4.

29. Cheah P.Y., Liong M.L., Yuen K.H., Teh C.L., Khor T., Yang J.R., Yap H.W.,Krieger J.N. Chronic prostatitis: symptom survey with follow-up clinical evaluation. Urology. 2003;61(1):60–64.

30. Urology. Russian clinical guidelines. Ed. Yu.G. Alyaev, P.V. Glybochko, D.Yu. Pushkar. 2017;544 p. Russian (Урология. Российские клинические рекомендации. Под ред. Ю.Г. Аляева, П.В. Глыбочко, Д.Ю. Пушкаря. 2017;544 с.).

31. Turner J.A., Ciol M.A., Von Korff M., Berger R. Validity and responsiveness of the national institutes of health chronic prostatitis symptom index. J Urol. 2003;169(2):580–583.

32. Shou J., Poulsen A.L., Nordling J. The value of a new symptom score (DAN-PSS) in diagnosing uro-dynamicinfravesical obstruction in BPH. Scand J Urol Nephrol 1993;27(4):489–492.

33. Rosen R., Altwein J., Boyle P. Lower urinary tract symptoms and male sexual dysfunction: the Multinational Survey of the Aging Male (MSAM–7). Eur. Urology. 2003;44:637–649.

34. Shestaev A.Yu., Protoshchak V.V., Paronnikov M.V., Kiselev A.O.Combined (citrate and vegetable) drug uriklar in remote lithotripsy and metaphylaxis of urolithiasis. Urologicheskie vedomosti. 2018;8(1):19–25. Doi:10.17816/uroved8119-25). Russian (Шестаев А.Ю., Протощак В.В., Паронников М.В., Киселев А.О. Комбинированный (цитратный и растительный) препарат уриклар в дистанционной литотрипсии и метафилактике мочекаменной болезни. Урологические ведомости. 2018;8(1):19–25. Doi:10.17816/uroved8119-25).

35. Shestaev A.Yu., Paronnikov M.V., Protoshchak V.V., Babkin P.A., Gul’ko A.M.,Kubin N.D. The effectiveness of anti-relapse therapy in patients with urolithiasis and metabolic syndrome. Vestnik Severo-Zapadnogo gosudarstvennogo meditsinskogo universiteta im. I.I. Mechnikova. 2013;5(2):85–89. Russian (Шестаев А.Ю., Паронников М.В., Протощак В.В.,Бабкин П.А., Гулько А.М., Кубин Н.Д. Эффективность противорецидивной терапии у больных мочекаменной болезнью и метаболическим синдромом. Вестник Северо-Западного государственного медицинского университета им. И.И. Мечникова. 2013;5(2):85–89).

36. Dzeranov N.K. Treatment of urolithiasis is a complex medical problem. Kachestvo zhizni. Meditsina. 2005;2(9):46–51. Russian (Дзеранов Н.К.Лечение мочекаменной болезни – комплексная медицинская проблема. Качество жизни. Медицина. 2005;2(9):46–51).

37. Penniston K.L., Nakada S.Y. Health related quality of life differs between male and female stone formers. J Urol. 2007;178(6):2435–40. Discussion 2440. Epub 2007 Oct 15.

38. Penniston K.L., Antonelli J.A., Viprakasit D.P., Averch .TD., Sur R.L.,Pais V.M. Jr., Chew B.H., Bird V.G., Nakada S.Y. Validation and Reliability of the Wisconsin Stone Quality of Life Questionnaire. J Urol. 2017;197(5):1280–88. Doi:10.1016/j.juro. 2016.11.097. Epub 2016 Nov 23.

39. Jackson M.J., Sciberras J., Mangera A., Brett A., Watkin N., N’dow J.M.,Chapple C.R., Andrich D.E., Pickard R.S., Mundy A.R. Defining a patient-reported outcome measure for urethral stricture surgery. Eur Urol. 2011;60(1):60–68. Doi: 10.1016/j.eururo.2011.03.003. Epub 2011 Mar 17.

40. Bazaev V.V., Shibaev A.N., Pavlova Yu.V. Validation of the Russian-language version of the questionnaire to assess the effectiveness of surgical treatment of patients with stricture of the front urethra patient-reported outcome measure for urethral stricture surgery (PROM-USS): the results of the pilot study. Urologiia. 2015;5:15–21. Russian (Базаев В.В., Шибаев А.Н., Павлова Ю.В. Валидация русскоязычной версии опросника для оценки эффективности хирургического лечения пациентов со стриктурами передней уретры patient-reported outcome measure for urethral stricture surgery (PROM-USS): результаты пилотного исследования. Урология. 2015;5:15–21).

41. Donovan J., Peters T., Abrams P., Brooks S., de la Rosette J., Schafer W.Scoring the short form ICS male SF questionnaire. J Urol. 2000;164(6):1948–1955.

42. Peeling W.B. Diagnostic assessment of benign prostatic hyperplasia. Prostate.1989;2:51–68.

43. Health Policy. EuroQol – a new facility for the measurement of health-related quality of life. The EuroQol Group. 1990;16:199–208.

44. Bazaev V.V., Shibaev A.N., Pavlova Yu.V. Quality of life as a criterion of the effectiveness of surgical treatment of strictures of the anterior urethra. Urologiia. 2016;5:32–36. Russian (Базаев В.В., Шибаев А.Н., Павлова Ю.В.Качество жизни как критерий эффективности оперативного лечения стриктур передней уретры. Урология. 2016;5:32–36).

45. Kurenkov A.V., Komyakov B.K., Sharvadze K.O., Shpilenya E.S. Results of a study of the quality of life in elderly patients with incontinence. Meditsinskii vestnik Bashkortostana. 2015;10:3. Russian (Куренков А.В., Комяков Б.К.,Шарвадзе К.О., Шпиленя Е.С. Результаты исследования качества жизни у пациентов пожилого возраста с недержанием мочи. Медицинский вестник Башкортостана. 2015;10:3).

46. Ibinaeva I.S, Apoolikhina I.A., Makhmedzhanova F.N., Muslimova S.Z.ICIQ-SF questionnaire for women with urinary incontinence. Urologiia. 2012;1:38–42. Russian (Ибинаева И.С, Апоолихина И.А., Махмеджанова Ф.Н., Муслимова С.З. Анкета ICIQ-SF у женщин с недержанием мочи. Урология. 2012;1:38–42).

47. Coyne K., Revicki D., Hunt T. Psychometric validation of an overactivebladder symptom and health-related quality of life questionnaire the OAB-q. Qual. Life Res. 2002;11:563.

48. Kasyan G.R., Khodyreva L.A., Dudareva A.A., Tupikina N.V., Pushkar D.Yu. Syndrome of a hyperactive bladder. M., ABV-press. 2016. 14 p. Russian (Касян Г.Р., Ходырева Л.А., Дударева А.А., Тупикина Н.В., Пушкарь Д.Ю.Синдром гиперактивного мочевого пузыря. М., АБВ-пресс. 2016. 14 c.).

49. Kuz’min I.V., Shabudina N.O. Assessment of the quality of life of patients with diabetic and idiopathic hyperactivity of the bladder. Urologicheskie vedomosti. 2014.Tom IV:1 ISSN 2225-9074. Russian (Кузьмин И.В., Шабудина Н.О. Оценка качества жизни больных с диабетической и идиопатической гиперактивностью мочевого пузыря. Урологические ведомости. 2014.Том IV:1 ISSN 2225-9074).

50. Kuz’min I.V. Assessment of quality of life in patients with urinary bladder hyperactivity. Nefrologiya. 2006;10(4):93–97. Russian (Кузьмин И.В. Оценка качества жизни у больных с гиперактивностью мочевого пузыря. Нефрология. 2006;10(4):93–97).

51. Kalsi V., Apostolidis A., Popat R. Quality of life changes in patients with neurogenic versus idiopathic detrusor overactivity after intradetrusor injections of botulinum neurotoxin type A and correlations with lower urinary tract symptoms and urodynamic changes. Eur. Urol. 2006;49(3):528–535.

52. Lai H.H., Shen B., Rawal A., Vetter J. The relationship between depression and overactive bladder/urinary incontinence symptoms in the clinical OAB population. BMC Urol. 2016;16:60. Published online 2016 Oct 6. Doi: 10.1186/s12894-016-0179-x.

53. Brookes S., Donovan J,. Wright M., Jackson S., Abrams P. A Scored form of the Bristol Lower Urinary Tract Symptoms questionnaire: data from a randomized controlled trial of surgery for women with stress incontinence. Am.J.Obstet.Gynecol. 2004;191(1):73–82.

54. Donovan J., Abrams P., Peters T. The ICSBPH study: the psychometric validity and reliability of the ICSmale questionnaire. B.J.U. 1996;77:554.

55. Jackson S., Donovan J., Brooks S. The Bristol Female Lower Urinary Tract Symptoms questionnaire: and psychometric testing. B.J.U. 1996;77:805.

56. Pushkar’ D.Yu., Govorov A.V., Sidorenkov A.V., Prilepskaya E.A., Kovylina M.V. Early diagnosis of prostate cancer. Methodical recommendations № 19. M.: OOO «Izdatel’skii dom «ABV-press», 2015;52 p. Russian (Пушкарь Д.Ю., Говоров А.В., Сидоренков А.В., Прилепская Е.А., Ковылина М.В. Ранняя диагностика рака предстательной железы. Методические рекомендации № 19. М.: ООО «Издательский дом «АБВ-пресс», 2015;52 с.).

57. The state of cancer care for the population of Russia in 2014. Ed.. A.D. Kaprin, V.V. Starinskii, G.V. Petrova. M., 2015. Russian (Состояние онкологической помощи населению России в 2014 году. Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М., 2015).

58. Arkhipova O.E., Chernogubova E.A., Likhtanskaya N.V., Kulygin V.V., Sheverdyaev I.V., Kurolap S.A., Eprintsev S.A., Tarasov V.A., Matishov D.G.(red.) Spatial-temporal analysis of the incidence of cancer as an indicator of medical and environmental safety. Rostov-na-Donu: Izd-vo Yuzhnogo nauchnogo tsentra RAN. 2014;224 p. Russian (Архипова О.Е., Черногубова Е.А., Лихтанская Н.В., Кулыгин В.В., Шевердяев И.В., Куролап С.А., Епринцев С.А., Тарасов В.А., Матишов Д.Г. (ред.) Пространственно-временной анализ встречаемости онкологических заболеваний как индикатора медико-экологической безопасности. Ростов-на-Дону: Изд-во Южного научного центра РАН. 2014;224 с.).

59. Litwin M.K., Hays R.D., Fink A. The UCLA Prostate Cancer Index: Development, reliability, and validity of a health-related quality of life measure. Med. Care. 1998;36:1006.

60. Litwin M.S., McGuigan K. Accuracy of recall in health-related quality of life assessment among men treated for prostate cancer. J. Clin. Oncol. 1999;17:2882.

61. Petrov S.B., Rakul S.A. Prostate cancer and quality of life. Onkourologiya. 2006;4:9–14. Russian (Петров С.Б., Ракул С.А. Рак предстательной железы и качество жизни. Онкоурология. 2006;4:9–14).

62. Esper P., Mo F., Chodak G. Measuring Qua¬lity of life in men with prostate cancer using the Functional Assessment of Cancer Therapy-Prostate (FACT-P) instrument. Urology. 1997;50:920.

63. Wei J.T., Dunn R.L., Litwin M.S. Development and validation of the expanded prostate can¬cer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology. 2000;56:899.

64. Aaronson N.K. Prostate cancer module: QLQPR25. Phase IV module. Disponible de: www. eortc.be/home/QV/QLGprojects.htm#Prostate.

65. Da Silva Е.С., Fossa S.D., Aaronson N.K. The quality of life of patients with newly diagnosed Ml prostate cancer: experience with EORTC clinical trial 30853. Eur J Cancer 1996;32A(1):72–77.

66. Augustin H., Pummer К., Daghofer F. Patient self-reporting questionnaire on urological morbidity and bother after radical retropubic prostatectomy. Eur Urol 2002;42(2):112–117.

67. Korneev I.A., Alekseeva T.A., Kogan M.I., Pushkar D.Yu. Epidemiology of urination disorders in men of the Russian Federation. Urologiia. 2016;2:70–75. Russian (Корнеев И.А., Алексеева Т.А., Коган М.И., Пушкарь Д.Ю. Эпидемиология расстройств мочеиспускания у мужчин Российской Федерации. Урология. 2016;2:70–75).

68. Bellardita L., Rancati T., Alvisi M.F., Villani D., Magnani T., Marenghi C.,Nicolai N., Procopio G., Villa S., Salvioni R., Valdagni R. Predictors of health-related quality of life and adjustment to prostate cancer during active surveillance. Eur Urol 2013;64(1):30–36.

69. Komyakov B.K., Guliev B.G., Sergeev A.V., Fadeev V.A., Ul’yanov A.Yu., Savashinskii Ya.S., Kas’yanenko S.S. Survival of patients with bladder cancer after radical cystectomy.. Onkourologiya. 2016;1(12):40–46. Russian (Комяков Б.К., Гулиев Б.Г., Сергеев А.В., Фадеев В.А., Ульянов А.Ю., Савашинский Я.С., Касьяненко С.С. Выживаемость больных раком мочевого пузыря после радикальной цистэктомии. Онкоурология. 2016;1(12):40–46).

70. Simons J.P., Aaronson N.K., Vansteenkiste J.F. Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: a placebocontrolled multicenter study. J Clin Oncol. 1996;14(4):1077–1084.

71. Coast J., Peters T.J., Richards S.H., Gunnell D.J. Use of the EuroQOL among elderly acute care patients. Qual Life Res 1998;7:1:1–10.

72. Ponukalin A.N., Glybochko P.V., Blyumberg B.I., Galkina N.G., Mikhailov V.Yu.Effect of the method of urine diversion on long-term results and quality of life in patients with bladder cancer after radical cystectomy.. Meditsinskii vestnik Bashkortostana. 2011:195–200. Russian (Понукалин А.Н., Глыбочко П.В., Блюмберг Б.И., Галкина Н.Г., Михайлов В.Ю. Влияние метода деривации мочи на отдаленные результаты и качество жизни у больных раком мочевого пузыря после радикальной цистэктомии. Медицинский вестник Башкортостана. 2011:195–200).

73. Lelyavin K.B., Dvornichenko V.V. Quality of life of patients after radical treatment of bladder cancer. Saratovskii nauchno-meditsinskii zhurnal. 2008;3(21):97–101. Russian (Лелявин К.Б., Дворниченко В.В. Качество жизни больных после радикального лечения рака мочевого пузыря. Саратовский научно-медицинский журнал. 2008;3(21):97–101).

74. Gopalakrishna A., Longo T.A., Fantony J.J., Van Noord M., Inman B.A. Lifestyle factors and health-related quality of life in bladder cancer survivors: a systematic review. J Cancer Surviv. 2016;10(5):874–82. Doi: 10.1007/s11764-016-0533-8. Epub 2016 Mar 21.

75. Keimling M., Behrens G., Schmid D., Jochem C., Leitzmann M.F. The association between physical activity and bladder cancer: systematic review and meta-analysis. Br J Cancer. 2014;110(7):1862–1870. Doi: 10.1038/bjc.2014.77. Epub 2014 Mar 4.

76. Cella D., Yount S., Du H., Dhanda R., Gondek K., Langefeld K., George J.,Bro W.P., Kelly C., Bukowski R. Development and validation of the Functional Assessment of Cancer Therapy-Kidney Symptom Index (FKSI). J Support Oncol. 2006;4(4):191–199.

77. Cella D., Yount S., Brucker P.S., Du H., Bukowski R., Vogelzang N., Bro W.P.Development and validation of a scale to measure disease-related symptoms of kidney cancer. Value Health. 2007;10(4):285–293.

78. Alekseev B.Ya., Shegai P.V. Target therapy for advanced kidney cancer. Meditsinskie novosti. 2010;9:6–11. Russian (Алексеев Б.Я., Шегай П.В. Таргетная терапия распространенного рака почки. Медицинские новости. 2010;9:6–11).

79. Bondar’ G.V., Anishchenko A.A. Quality of life of patients with urothelial kidney cancer with various variants of adjuvant chemotherapy. Novoutvorennya. 2010;5:126–30. Russian (Бондарь Г.В., Анищенко А.А.Качество жизни больных уротелиальным раком почки при различных вариантах адъювантной химиотерапии. Новоутворення. 2010;5:126–130).

80. Beisland E., Beisland C., Hjelle K.M., Bakke A., Aarstad A.K., Aarstad H.J. Health-related quality of life, personality and choice of coping are related in renal cell carcinoma patients. Scand J Urol. 2015;49(4):282–289. Doi: 10.3109/21681805.2014.990051. Epub 2014 Dec 17.

81. Beisland E., Aarstad H.J., Aarstad A.K., Bakke A., Bostad L., Beisland C. Development of a disease-specific health-related quality of life (HRQoL) questionnaire intended to be used in conjunction with the general European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ) in renal cell carcinoma patients. Acta Oncol. 2016;55(3):349–356. Doi: 10.3109/0284186X.2015.1063776. Epub 2015 Aug 7.

82. Karimi M., Brazier J. Health, Health-Related Quality of Life, and Quality of Life: What is the Difference? Pharmacoeconomics. 2016;34(7):645–649. Doi: 10.1007/s40273-016-0389-9.

83. Kuznetsov I.V. People of Russian science. Technique: Essays on outstanding figures in science and technology. Moskva: Nauka. 1965;1:338. Russian (Кузнецов И.В. Люди русской науки. Техника: Очерки о выдающихся деятелях естествознания и техники. Москва: Наука. 1965;1:338).